IGF1 and schizophrenia: Age was significantly negatively correlated with serum IGF-1 levels in patients with MDD (R = − 0.54, p < 0.01) and schizophrenia (R = − 0.47, p < 0.01), and controls (R = − 0.55, p < 0.01).